Skip to main content

Mack Daniel

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Mack Daniel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

AYTU Aytu Biopharma, Inc

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 9, 2025 (view filing)4:31 PM ETJun 63 daysNantahala Capital Management, LLC and 2 others10% OwnerPPurchase+4.00M$1.50+$6.00M–4.82M afterDerivative

EVOK Evoke Pharma Inc

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 30, 2025 (view filing)6:39 PM ETJan 282 daysNantahala Capital Management, LLC and 2 others10% OwnerSSale−41$4.39−$179.870.0%148.2K after